Personalized blood test aims to track stomach and colon cancer spread
NCT ID NCT04929015
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with gastrointestinal cancer that has spread to the lining of the abdomen. Researchers will collect tumor tissue and blood samples to create a custom blood test that looks for cancer DNA. The goal is to see if this test can help doctors monitor the cancer over time and guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APPENDIX CARCINOMA BY AJCC V8 STAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RWJBarnabas Health - Cooperman Barnabas, Livingston
Livingston, New Jersey, 07039, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Lab-Grown tumor models predict the best therapy for each patient?
- A simple blood draw could spot colorectal cancer early
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a Cancer-Fighting virus shrink tumors when chemo fails?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- AI-Powered app aims to transform colorectal cancer recovery monitoring